Literature DB >> 8505765

Post anoxic action myoclonus.

A J Larner, M T Heafield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8505765      PMCID： PMC1294027     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  9 in total

1.  Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.

Authors:  S Fahn
Journal:  Adv Neurol       Date:  1986

Review 2.  Posthypoxic action myoclonus: literature review update.

Authors:  S Fahn
Journal:  Adv Neurol       Date:  1986

3.  [Intention and post-anoxic action myoclonias. Amelioration by piracetam].

Authors:  C Cremieux; G Serratrice
Journal:  Nouv Presse Med       Date:  1979-10-29

4.  Posthypoxic myoclonus (the Lance-Adams syndrome) in the intensive care unit.

Authors:  S J Harper; R G Wilkes
Journal:  Anaesthesia       Date:  1991-03       Impact factor: 6.955

5.  [Therapeutic effect of piracetam in a case of posthypoxic action myoclonus (author's transl)].

Authors:  G Terwinghe; J Daumerie; C Nicaise; O Rosillon
Journal:  Acta Neurol Belg       Date:  1978 Jan-Feb       Impact factor: 2.396

Review 6.  Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.

Authors:  P Jenner; J A Pratt; C D Marsden
Journal:  Adv Neurol       Date:  1986

7.  Piracetam: physiological disposition and mechanism of action.

Authors:  M T Tacconi; R J Wurtman
Journal:  Adv Neurol       Date:  1986

8.  Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs.

Authors:  A Coletti; A Mandelli; G Minoli; G Tredici
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

9.  The treatment of severe action myoclonus.

Authors:  J A Obeso; J Artieda; J C Rothwell; B Day; P Thompson; C D Marsden
Journal:  Brain       Date:  1989-06       Impact factor: 13.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.